OPTI vs. CYAN, PHE, OKYO, IGAS, CRDL, ALT, REVB, IDP, BON, and BSFA
Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include CyanConnode (CYAN), PowerHouse Energy Group (PHE), OKYO Pharma (OKYO), IGas Energy (IGAS), Cordel Group (CRDL), Altitude Group (ALT), Revolution Beauty Group (REVB), InnovaDerma (IDP), Bonmarche (BON), and BSF Enterprise (BSFA). These companies are all part of the "pharmaceutical products" industry.
OptiBiotix Health vs. Its Competitors
CyanConnode (LON:CYAN) and OptiBiotix Health (LON:OPTI) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.
In the previous week, CyanConnode had 2 more articles in the media than OptiBiotix Health. MarketBeat recorded 3 mentions for CyanConnode and 1 mentions for OptiBiotix Health. OptiBiotix Health's average media sentiment score of 0.67 beat CyanConnode's score of -0.33 indicating that OptiBiotix Health is being referred to more favorably in the news media.
OptiBiotix Health has lower revenue, but higher earnings than CyanConnode. CyanConnode is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.
CyanConnode has a net margin of -20.45% compared to OptiBiotix Health's net margin of -524.43%. CyanConnode's return on equity of -28.94% beat OptiBiotix Health's return on equity.
CyanConnode has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.
29.1% of CyanConnode shares are owned by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are owned by institutional investors. 17.8% of CyanConnode shares are owned by company insiders. Comparatively, 12.0% of OptiBiotix Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
CyanConnode beats OptiBiotix Health on 8 of the 13 factors compared between the two stocks.
Get OptiBiotix Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OptiBiotix Health Competitors List
Related Companies and Tools
This page (LON:OPTI) was last updated on 7/26/2025 by MarketBeat.com Staff
